Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: a randomized proof-of-concept study.
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.06.010
Abstract: OBJECTIVES To assess pharmacodynamic and pharmacokinetic outcomes of a novel copper (Cu) intrauterine system (IUS) releasing ulipristal acetate (UPA) in healthy women. STUDY DESIGN In this single-blinded, randomized proof-of-concept study, ovulatory women received one of… read more here.
Keywords: copper intrauterine; releasing ulipristal; randomized proof; study ... See more keywords
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device.
Sign Up to like & getrecommendations! Published in 2022 at "Personalized medicine"
DOI: 10.2217/pme-2022-0060
Abstract: Aim: This study aimed to explore the genetic risk factors and validate variants of abnormal uterine bleeding after copper intrauterine device insertion. Methods: Whole-exome sequencing was performed and several variants were validated by Sequenom MassARRAY. Results: Eight… read more here.
Keywords: abnormal uterine; uterine bleeding; whole exome; copper intrauterine ... See more keywords